Rubin, Alan A.
February 1963
Angiology;Feb1963, Vol. 14 Issue 2, p74
Academic Journal
Evaluates the hemodynamic properties of antihypertensive agents. Primary hemodynamic change in hypertension; Dangers of inaccurate antihypertensive therapy; Citation of certain experiments on the efficacy of several antihypertensive agents.


Related Articles

  • Lisinopril for the Treatment of Hypertension Within the First 24 Hours of Acute Ischemic Stroke and Follow-Up. Eveson, David J.; Robinson, Thompson G.; Potter, John F. // American Journal of Hypertension;Mar2007, Vol. 20 Issue 3, p270 

    Background: Hypertension immediately after acute ischemic stroke is associated with impaired morbidity and mortality, although there are few data on antihypertensive use immediately after ictus. This randomized, double-blinded, placebo-controlled, parallel-group study explored the hemodynamic...

  • Hypertension in Infantile Polycystic Renal Disease. Rahill, W. Joseph; Rubin, Mitchell I. // Clinical Pediatrics;Apr1972, Vol. 11 Issue 4, p232 

    Two infants with polycystic renal disease and severe hypertension had studies of renal function and antihypertensive therapy. One infant with adequate renal function died with uncontrolled hypertenson. The second infant's blood pressure approached normal; now three and one-half years of age, he...

  • Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial. Gueyffier, F; Subtil, F; Bejan-Angoulvant, T; Zerbib, Y; Baguet, J P; Boivin, J M; Mercier, A; Leftheriotis, G; Gagnol, J P; Fauvel, J P; Giraud, C; Bricca, G; Maucort-Boulch, D; Erpeldinger, S // Journal of Human Hypertension;Jan2015, Vol. 29 Issue 1, p22 

    Current antihypertensive strategies do not take into account that individual characteristics may influence the magnitude of blood pressure (BP) reduction. Guidelines promote trial-and-error approaches with many different drugs. We conducted the Identification of the Determinants of the Efficacy...

  • RESISTANT HYPERTENSION OFTEN DUE TO INSUFFICIENT THERAPY.  // Heart Advisor;Oct2013, Vol. 16 Issue 10, p2 

    The article discusses a study published in the journal "Circulation" which indicates that more than 15 percent of patients with treatment-resistant hypertension may encounter higher risk of resistant hypertension due to insufficient optimal antihypertensive therapy.

  • Blood pressure management. Fallon, Noeleen // World of Irish Nursing & Midwifery;Apr2006, Vol. 14 Issue 4, p35 

    The article focuses on blood pressure management. It defines blood pressure as the pressure exerted within the blood vessel walls as the heart pumps and circulates the blood around the body. It defines hypertension as the level of blood pressure above which intervention has been shown to reduce...

  • Predictors of Antihypertensive Drug Responses: Initial Data from a Placebo-Controlled, Randomized, Cross-Over Study With Four Antihypertensive Drugs (The GENRES Study). Hiltunen, Timo P.; Suonsyrjä, Timo; Hannila-Handelberg, Tuula; Paavonen, Kristian J.; Miettinen, Helena E.; Strandberg, Timo; Tikkanen, Ilkka; Tilvis, Reijo; Pentikäinen, Pertti J.; Virolainen, Juha; Kontula, Kimmo // American Journal of Hypertension;Mar2007, Vol. 20 Issue 3, p311 

    Background: Only a minority of hypertensive individuals is adequately controlled for their hypertension, partially because reliable predictors for efficient antihypertensive drug therapy are lacking. Methods: In a prospective, randomized, double-blind, cross-over, placebo-controlled study (The...

  • Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients. Odili, Augustine N; Ezeala-Adikaibe, Birinus; Ndiaye, Mouhamadou B; Anisiuba, Benedict C; Kamdem, Marius M; Ijoma, Chinwuba K; Kaptue, Joseph; Boombhi, Hilaire J; Kolo, Philip M; Shu, Elvis N; Thijs, Lutgarde; Stassen, Jan A; Omotoso, Babatunde A; Kingue, Samuel; Ba, Serigne A; Lemogoum, Daniel; M'Buyamba-Kabangu, Jean-René; Ulasi, Ifeoma I // Trials;2012, Vol. 13 Issue 1, p59 

    Background: The epidemic surge in hypertension in sub-Saharan Africa is not matched by clinical trials of antihypertensive agents in Black patients recruited in this area of the world. We mounted the Newer versus Older Antihypertensive agents in African Hypertensive patients (NOAAH) trial to...

  • Sitaxentan in Pulmonary Arterial Hypertension: A Viewpoint by Steven Kawut.  // Drugs;2007, Vol. 67 Issue 5, p771 

    The article discusses the author's viewpoint concerning the sitaxentan in pulmonary arterial hypertension. Pulmonary arterial hypertension (PAH) causes significant functional limitations and an increased risk of health. Endothelin (ET)-1 is increased both locally and systematically in patient...

  • Complications of hypertensive emergencies are usually reversible with prompt diagnosis and treatment.  // Drugs & Therapy Perspectives;Apr2004, Vol. 20 Issue 4, p10 

    Although systemic hypertension is a common clinical disorder, hypertensive emergencies occur relatively infrequently in clinical practice. However, when they do occur, it is vital that they are diagnosed rapidly as immediate lowering of blood pressure (BP) is necessary to minimize or reverse any...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics